Panchsheel Q1 FY27: PAT Rs 231L, Rs 0.80 dividend, new MD after demise

EBITDA margin compressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.2%Reaction day

₹122.90

prior close

₹118.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-3.3% vs market

Pharmaceuticals peers, median of 167sector-0.3%-2.8% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-2.5

15m

+0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.2+0.1-3.3-0.3-2.8

Next day

-5.5+0.5-6.0-0.0-5.4

-2.4-0.1-2.3-0.7-1.6

-1.1+0.4-1.5-0.4-0.7

-3.4+0.7-4.1-0.7-2.8

-4.7+0.9-5.6-0.5-4.1

-4.0+1.1-5.1-0.7-3.3

15d

-14.0+1.6-15.6+1.4-15.4

-10.6-0.7-9.8+0.6-11.2

-15.4-3.2-12.1-4.1-11.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 revenue from operations at Rs 2,466.77 lacs, up 4.7% YoY from Rs 2,356.20 lacs, but net profit fell 18.7% YoY to Rs 231.20 lacs and EBITDA margin compressed to 15.6% from 18.7%. Board declared Rs 0.80 per share interim dividend (record date Aug 21). After quarter-end, MD Mahendra Turakhia passed away on Aug 2; Kishor Turakhia elevated to MD.

Likely market impact

Lower profits despite revenue growth and dividend is positive for shareholders. Leadership transition after MD demise creates short-term uncertainty.